Latest Breaking News On - International blood - Page 3 : comparemela.com

City of Hope to Unveil New Cancer Treatments at 2024 ASCO Meeting

Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Undergoing Stem Cell Transplant for Myelofibrosis

The procedure offers a potential cure, but comes with a risk of early morbidity and mortality

Despite enduring disparities, stem cell transplants expand across all races, ethnicities

The amount of autologous and allogeneic hematopoietic stem cell transplants for hematologic disorders has increased over time in tandem with longer survival, according to results of an observational study. Researchers observed improvements across all racial and ethnic groups but found that disparities related to treatment outcomes still exist.

Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation